4
Changes in Ownership
Altimmune, Inc. Filed Acc 0001144204-10-025957
Options or other derivatives
- SVP, Chief Scientific Officer acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
FUERST THOMAS RICHARD · SVP, Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2010-05-06 | Grant or award : show line 1 in the form Stock Option (right to buy) | +20,000 | $1.38 | 2020-05-06 | 20,000 | 20,000 | D |
Loading xslF345X03/v184299_ex.xml…